Cardio-protection and monitoring for early phase clinical trials: Recommendations from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortium
Year: 2026
Type: article
DOI: 10.1093/jnci/djag393
Authors: Susan I Colace, Lauren Pommert, Kasey J Leger, Teresa Rushing, Kristine R Crews, Colleen Annesley, M Brooke Bernhardt, Laura B Ramsey, Nicole Kaiser, Deepa Bhojwani, Alan S Wayne, Todd M Cooper, Susan R Rheingold, Andrew E Place, Bill H Chang, Maria Luisa Sulis, Melinda Pauly, Paul S Gaynon, Ritu Sachdeva, Eric S Schafer, Himalee S Sabnis
Institutions: Nationwide Children's Hospital, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Seattle Children's Hospital, Center for Cancer and Blood Disorders, Children's Hospital of Los Angeles, St. Jude Children's Research Hospital, Children's Mercy Hospital, Children's Hospital Colorado, University of Colorado Denver, University of Southern California, USC Norris Comprehensive Cancer Center, Children's Hospital of Philadelphia, Harvard University, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Oregon Health & Science University, Memorial Sloan Kettering Cancer Center, Emory University, Children's Healthcare of Atlanta, Baylor College of Medicine
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7222964922
FWCI:
Cites:
Cited by:
Related to: